Oral Oncology
Volume 38, Issue 7 , Pages 691-698 , October 2002

Decreased expression of bcl-2 in moderate and severe oral epithelia dysplasias

  • Lado Lako Loro

      Affiliations

    • Department of Odontology—Oral Pathology and Forensic Odontology, The Gade Institute, Haukeland University Hospital, N5021 Bergen, Norway
    • Centre for International Health, University of Bergen, N5021 Bergen, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47-55-97-3231; fax: +47-55-97-3158
    • ,
  • Anne Christine Johannessen

      Affiliations

    • Department of Odontology—Oral Pathology and Forensic Odontology, The Gade Institute, Haukeland University Hospital, N5021 Bergen, Norway
    • ,
  • Olav Karsten Vintermyr

      Affiliations

    • Department of Pathology, The Gade Institute, Haukeland University Hospital, N5021 Bergen, Norway

Received 3 December 2001 ,Accepted 8 January 2002.

References 

  1. Silverman S, Sugerman PB. Oral premalignancies and squamous cell carcinoma. Clin Dermatol. 2000;18(5):563–568
  2. Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. J Pathol. 2001;194(3):294–297
  3. Subdø J, Byrne M, Johannessen AC, Reith A. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia. J Pathol. 2001;194(3):303–310
  4. Wyllie AH, Bellamy CO, Bubb VJ, Clarke AR, Corbet S, Curtis L, et al.  Apoptosis and carcinogenesis. Br J Cancer. 1999;80:34–37
  5. Tsujimoto Y, Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett. 2000;466(1):6–10
  6. Guo M, Hay BA. Cell proliferation and apoptosis. Curr Opin Cell Biol. 1999;11(6):745–752
  7. Antonsson B, Martinou J-C. The Bcl-2 protein family. Exp Cell Res. 2000;256(1):50–57
  8. Jiang ZH, Wu JY. Alternative splicing and programmed cell death. Proc Soc Exp Biol Med. 1999;220(2):64–72
  9. Tsujimoto Y, Croce C. Analysis of the structure, transcripts, and protein products of Bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA. 1986;83(1):5214–5218
  10. Thomas AL, Price C, Martin SG, Carmichael J, Murray JC. Identification of two novel mRNA splice variants of bax. Cell Death Diff. 1999;6(2):97–98
  11. Loro LL, Vintermyr OK, Liavaag PG, Jonsson R, Johannessen AC. Oral squamous cell carcinoma is associated with decreased blc-2/bax expression ratio and increased apoptosis. Human Pathol. 1999;30(9):1097–1105
  12. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histological typing of cancer and precancer of the oral mucosa. World Health Organisation International Classification of Tumours. Berlin: Springer; 1997;
  13. Chleq-Deschamps CM, LeBrun DP, Huie P, Besnier DP, Warnke RA, Sibley RK, et al.  Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. Blood. 1993;81(2):293–298
  14. Gazzaniga P, Gradilone A, Vercillo R, Gandini O, Silvestri I, Napolitano M, et al.  bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer. Int J Cancer. 1996;69(2):100–104
  15. Oltvai ZN, Millian CL, Korsmeyer S. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74(4):609–619
  16. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119(3):493–501
  17. Loro LL, Vintermyr OK, Ibrahim SO, Idris AM, Johannessen AC. Apoptosis and expression of bax and bcl-2 in snuff- and non-snuff associated oral squamous cell carcinomas. Anticancer Res. 2000;20:2855–2860
  18. Chen-Levy Z, Nourse J, Cleary ML. The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol Cell Biol. 1989;9(2):701–710
  19. Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med. 1988;318(25):1638–1644
  20. Teixeira C, Reed JC, Pratt MA. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 1995;55(17):3902–3907
  21. Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, et al.  Bcl-2/Bax protein ratio predicts 5-fuorouracil sensitivity independently of p53 status. Br J Cancer. 2000;83(10):1380–1386
  22. Korner I, Weber-Nordt R, Pfaff P, Finke J. Analysis of a regulatory element in the 5′-untranslated region of the bcl-2 gene. FEBS Lett. 1997;406(1):31–32
  23. Jordan RCK, Catzavelos GC, Barrett AW, Speight PM. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Oral Oncol, Eur J Cancer. 1996;32B(6):394–400
  24. Singh BB, Chandler FW, Whitaker SB, Forbes-Nelson AE. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surg Oral Med Oral Pathol Oral Radio Endod. 1998;85(6):692–698
  25. Ravi D, Ramadas K, Mathew BS, Nalinakumari KR, Nair MK, Pillai MR. De novo programmed cell death in oral cancer. Histopathol. 1999;34(3):241–249
  26. Yao L, Iwai M, Furuta I. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol. 1999;35(1):56–62
  27. Schoelch ML, Le QT, Silverman S, McMillan A, Dekker NP, Fu KK, et al.  Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol. 1999;35(1):77–85
  28. McAlinden RL, Maxwell P, Napier S, Hailton P, Cowan CG, Lundy FT, et al.  Bcl-2 expression in sequential biopsies of potentially malignant oral mucosal lesions assessed by immunocytochemistry. Oral Dis. 2000;6(5):318–326
  29. Morales-Ducret CR, van de Rijn M, Smoller BR. bcl-2 expression in melanocytic nevi. Insights into the biology of dermal maturation. Arch Dermatol. 1995;131(8):915–918
  30. Goldblum JR, Rice TW. bcl-2 protein expression in the Barrett's metaplasia-dysplasia-carcinoma sequence. Mod Pathol. 1995;8(8):866–869
  31. Walker C, Robertson L, Myskow M, Dixon G. Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer. 1995;72(1):164–169
  32. Berney CR, Downing SR, Yang J, Russell PJ, Crowe PJ. Evidence of post-transcriptional down-regulation of the apoptosis-related gene bcl-2 in human colorectal cancer. J Pathol. 2000;191(1):15–20
  33. Williams HK. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol. 2000;53(4):165–172
  34. Schwarzt JL, Gu X, Kittles RA, Baptsite A, Shklar G. Experimental oral carcinoma of the tongue and buccal mucosa: possible biological markers linked to cancers at two anatomic sites. Oral Oncol. 2000;36(2):225–235

PII: S1368-8375(02)00002-7

Oral Oncology
Volume 38, Issue 7 , Pages 691-698 , October 2002

Article Tools

* Image Usage & Resolution